Optimization for Laryngeal Mask Removal Strategy and Evaluation of Transitional Criteria From PACU in Children
NCT ID: NCT04711174
Last Updated: 2022-04-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3 participants
OBSERVATIONAL
2020-07-31
2022-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Laryngeal Mask Airway and Endotracheal Intubation on Mechanical Power in Pediatric Patients
NCT07252674
Oropharyngeal Airway and Airway Complications
NCT05218707
Timing of Withdrawal of the Laryngeal Mask Airway (LMA) in Children
NCT03105739
Application of Visual Laryngeal Mask Airway Combined With Endotracheal Intubation in General Anesthesia
NCT04719767
Laryngeal Mask Airway Removal During Deep Anesthesia in Children
NCT01841866
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
movement,high Aldrete score group (MH group)
LMA removal be conducted when the child's spontaneous respiratory recovers with body movement spontaneously, and the child be transited from PACU when Aldrete score reaches 9
LMA removal
the timing when conducting LMA removal
movement,low Aldrete score group (ML group)
LMA removal be conducted when the child's spontaneous respiratory recovers with body movement spontaneously, and the child be transited from PACU when Aldrete score reaches 7
LMA removal
the timing when conducting LMA removal
sedation,high Aldrete score group (SH group)
LMA removal be conducted when the child's spontaneous respiratory recovers but with no body movement, and the child be transited from PACU when Aldrete score reaches 9
LMA removal
the timing when conducting LMA removal
sedation,low Aldrete score group (SL group)
LMA removal be conducted when the child's spontaneous respiratory recovers but with no body movement, and the child be transited from PACU when Aldrete score reaches 7
LMA removal
the timing when conducting LMA removal
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LMA removal
the timing when conducting LMA removal
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for general anesthesia
Exclusion Criteria
* Respiratory system deformity
* Respiratory infection in 4 weeks
6 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eye & ENT Hospital of Fudan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wenxian Li
Role: PRINCIPAL_INVESTIGATOR
Eye and ENT Hospital of Fudan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eye and EENT hospital of Fudan University
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LMA removal strategy
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.